HESI Pharmacology Exam Review 2025 – Ultimate Practice Resource with Realistic Questions, Nursing-Focused Explanations, and Expert Prep Tools

• Ultimate prep for HESI Pharmacology Exam 2025
• Realistic questions with nursing-focused explanations
• Expert prep tools for nursing students
• Sharpens pharmacology skills for RN candidates
• Builds confidence for exam success

Preview

1.) A client is being treated for acute congestive heart failure with intravenously
administered bumetanide. The vital signs are as follows: blood pressure, 100/60 mm Hg;
pulse, 96 beats/min; and respirations, 24 breaths/min. After the initial dose, which of the
following is the priority assessment?
1. Monitoring weight loss
2. Monitoring temperature
3. Monitoring blood pressure
4. Monitoring potassium level – – correct ans- -3. Monitoring blood pressure Rationale:
Bumetanide is a loop diuretic. Hypotension is a common side effect associated with the use
of this medication. The other options also require assessment but are not the priority.
**priority ABCs—airway, breathing, and circulation**
2.) Intravenous heparin therapy is prescribed for a client. While implementing this
prescription, a nurse ensures that which of the following medications is available on the
nursing unit?
1. Protamine sulfate
2. Potassium chloride
3. Phytonadione (vitamin K )
4. Aminocaproic acid (Amicar) – – correct ans- -1. Protamine sulfate Rationale:
The antidote to heparin is protamine sulfate; it should be readily available for use if excessive
bleeding or hemorrhage occurs. Potassium chloride is administered for a potassium deficit.
Vitamin K is an antidote for warfarin sodium. Aminocaproic acid is the antidote for
thrombolytic therapy.
3.) A client is diagnosed with pulmonary embolism and is to be treated with streptokinase
(Streptase). A nurse would report which priority data collection finding to the registered
nurse before initiating this therapy?
1. Adventitious breath sounds
2. Temperature of 99.4° F orally
3. Blood pressure of 198/110 mm Hg
4. Respiratory rate of 28 breaths/min – – correct ans- -3. Blood pressure of 198/110 mm Hg
Rationale:
Thrombolytic therapy is contraindicated in a number of preexisting conditions in which there
is a risk of uncontrolled bleeding, similar to the case in anticoagulant therapy. Thrombolytic
therapy also is contraindicated in severe uncontrolled hypertension because of the risk of
cerebral hemorrhage. Therefore the nurse would report the results of the blood pressure to
the registered nurse before initiating therapy. The findings in options 1, 2, and 4 may be
present in the client with pulmonary embolism.